Literature DB >> 30737732

Racial Differences in Smoking-related Disease Risk Perceptions Among Adults Completing Lung Cancer Screening: Follow-up Results from the ACRIN/NLST Ancillary Study.

Giselle K Perez1,2, Ilana F Gareen3,4, JoRean Sicks4, Christopher Lathan5,6, Alaina Carr7, Pallavi Kumar8, Colin Ponzani5, Kelly Hyland7,9, Elyse R Park7,5.   

Abstract

Previous work suggests that, compared to white adults, black adults have lower perceived risk for smoking-related diseases (SRDs), which may influence cessation behavior and health outcomes; however, racial differences in SRD risk perceptions among high-risk patients (i.e., a group that exhibits elevated risk for SRDs) following lung screening remain unknown. This paper thus examined differences in risk perceptions for lung cancer and other SRDs among black and white National Lung Screening Trial (NLST) participants. We administered a 10-item measure of perceived lifetime risk of lung cancer and other SRD (Smoking Risk Perceptions Scale; SRPS) to NLST participants at 1 year following lung screening to (1) establish the internal consistency of the SRPS for both black and white participants, (2) compare smoking-related disease risk perceptions between black and white participants, and (3) identify predictors of risk perceptions for black and white participants using multivariable linear regression models. We determined the SRPS items loaded onto two factors (personal and comparative risks; Cronbach's alpha = 0.93 and 0.95 for 1743 white and 194 black participants, respectively), thus demonstrating high internal consistency for both black and white adults. Compared to white participants, black adults demonstrated lower SRD risk perceptions (SRPS range = 10-50, mean difference = 2.55, SE = 0.50, p < 0.001), even after adjusting for smoking status and sociodemographics. Younger age, female gender, higher education, white race, and current smoking status were independently associated with high risk perceptions. Sociodemographic factors associated with lower risk perceptions resemble factors related to continued smoking. Findings suggest current and former black smokers are at risk of having lower risk perceptions for lung cancer and SRDs than white adults following lung cancer screening; these differences may explain observed racial differences in cessation outcomes. Although similar factors influence black and white adults' beliefs, risk perceptions may differentially impact smoking behavior among these groups. Behavior change models that guide tobacco treatment approaches, particularly for high-risk black smokers, should consider the influence of cultural factors on risk perceptions and cessation efforts.

Entities:  

Keywords:  Lung cancer; Racial disparities; Screening; Smoking cessation

Mesh:

Year:  2019        PMID: 30737732      PMCID: PMC6660997          DOI: 10.1007/s40615-019-00566-z

Source DB:  PubMed          Journal:  J Racial Ethn Health Disparities        ISSN: 2196-8837


  36 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Exploring the association between perceived risks of smoking and benefits to quitting: who does not see the link?

Authors:  Pauline Lyna; Colleen McBride; Greg Samsa; Kathryn I Pollak
Journal:  Addict Behav       Date:  2002 Mar-Apr       Impact factor: 3.913

Review 3.  Lung carcinoma in African Americans: a review of the current literature.

Authors:  J H Stewart
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

Review 4.  Developing a new model for cross-cultural research: synthesizing the Health Belief Model and the Theory of Reasoned Action.

Authors:  J E Poss
Journal:  ANS Adv Nurs Sci       Date:  2001-06       Impact factor: 1.824

5.  Smokers' unrealistic optimism about their risk.

Authors:  N D Weinstein; S E Marcus; R P Moser
Journal:  Tob Control       Date:  2005-02       Impact factor: 7.552

6.  The effect of race on invasive staging and surgery in non-small-cell lung cancer.

Authors:  Christopher S Lathan; Bridget A Neville; Craig C Earle
Journal:  J Clin Oncol       Date:  2005-12-19       Impact factor: 44.544

7.  Who gets chemotherapy for metastatic lung cancer?

Authors:  C C Earle; L N Venditti; P J Neumann; R D Gelber; M C Weinstein; A L Potosky; J C Weeks
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

8.  The influence of hospital volume on survival after resection for lung cancer.

Authors:  P B Bach; L D Cramer; D Schrag; R J Downey; S E Gelfand; C B Begg
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

9.  Smoking and mental illness: A population-based prevalence study.

Authors:  K Lasser; J W Boyd; S Woolhandler; D U Himmelstein; D McCormick; D H Bor
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

10.  Patient-centered communication, ratings of care, and concordance of patient and physician race.

Authors:  Lisa A Cooper; Debra L Roter; Rachel L Johnson; Daniel E Ford; Donald M Steinwachs; Neil R Powe
Journal:  Ann Intern Med       Date:  2003-12-02       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.